Influence of grapefruit juice on the pharmacokinetics of diltiazem in Wistar rats upon single and multiple dosage regimens

Pharmazie

Volumn 64, Issue 8, 2009, Pages 525-531

  Boddu, S P ^a   Yamsani, M Rao ^c   Potharaju, S ^e   Veeraraghavan, S ^b   Rajak, S ^b   Kumar VVS, S ^b   Avery, B A ^a,d   Repka, Michael A ^a,d   Varanasi, Kiran V S K ^b  

^a UNIVERSITY OF MISSISSIPPI   (United States)

^b Glenmark Pharmaceuticals Limited   (India)

^c KAKATIYA UNIVERSITY   (India)

^d UNIVERSITY OF MISSISSIPPI   (United States)

^e UNIVERSITY OF TENNESSEE HEALTH SCIENCE CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

DILTIAZEM; FELODIPINE; KETOCONAZOLE; ORGANIC ANION TRANSPORTER; PRAVASTATIN; RIFAMPICIN; VERAPAMIL; CALCIUM CHANNEL BLOCKING AGENT; CYTOCHROME P450 3A; DRUG;

ANIMAL EXPERIMENT; ARTICLE; CONTROLLED STUDY; DRUG ABSORPTION; DRUG DOSE REGIMEN; DRUG METABOLISM; DRUG TRANSPORT; FOOD DRUG INTERACTION; FRUIT JUICE; GRAPEFRUIT; INTESTINE ABSORPTION; MALE; MULTIPLE DRUG DOSE; NONHUMAN; RAT; SINGLE DRUG DOSE; ANIMAL; BEVERAGE; CELL FRACTIONATION; CHEMISTRY; DRUG INTERACTION; DUODENUM; HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; IN VITRO STUDY; LIVER; METABOLISM; WISTAR RAT;

ANIMALS; BEVERAGES; CALCIUM CHANNEL BLOCKERS; CHROMATOGRAPHY, HIGH PRESSURE LIQUID; CITRUS PARADISI; CYTOCHROME P-450 CYP3A; DILTIAZEM; DRUG INTERACTIONS; DUODENUM; FELODIPINE; INTESTINAL ABSORPTION; LIVER; MALE; PHARMACEUTICAL PREPARATIONS; RATS; RATS, WISTAR; SUBCELLULAR FRACTIONS;

EID: 70349769924     PISSN: 00317144     EISSN: None     Source Type: Journal    
DOI: 10.1691/ph.2009.9058     Document Type: Article

References (21)

1. Al-Saidan SM, Krishnaiah YS, Patro SS, Satyanaryana V (2005) In vitro and in vivo evaluation of guar gum matrix tablets for oral controlled release of water-soluble diltiazem hydrochloride. AAPS Pharm Sci Tech 6: E14-21.
2. Bailey DS, Munoz JC, Arnold J (1991) Interaction of citrus juices with felodipine and nefedipine. Lancet 337: 268-269.
3. Breschi C, Carelli V, Di Colo G, Nannipieri E (1981) Effect of tissue degeneration on drug transfer across in vitro rat intestine. Farmaco - Ed. Sc. 36: 166-180.
4. Buckley MMT, Grant SM, Goa KL, McTabish D, Sorkin EM (1990) Diltiazem A reappraisal of its pharmacological properties and therapeutic use. Drugs 39: 757-806.
5. Christensen H, Asberg A, Holmboe H, Berg KJ (2002) Coadministration of grapefruit juice increases systemic exposure of diltiazem in healthy volunteers. Eur J Clin Pharmacol 58: 515-520.
6. Dresser GK, Bailey DG, Leake BF, Schwarz UI, Dawson PA, Freeman DJ, Kim RB (2002) Fruit juices inhibit organic anion transporting polypeptide-mediated drug uptake to decrease the oral availability of fexofenadine. Clin Pharmacol Ther 71: 11-20.
7. Edwards DJ, Fitzimmons ME, Schuetz EG, Yasuda KMP, Warbasse LH, Woster PM, Schuetz JD, Watkins P (1999) 60,70-Dihydroxybergamottin in grapefruit juie and Seville orange juice: Effects on cyclosporine disposition, enterocyte CYP 3A, and P-glycoprotein. Clin Pharmacol Ther 65: 237-244.
8. Kane GC, Lipsky JJ (2000) Drug-grapefruit juice interactions. Mayo Clin Proc 75: 933-942.
9. Kantola T, Kivisto KT, Neuvonen PJ (1998) Grapefruit juice greatly increases serum concentrations of lovastatin and lovastatin acid. Clin. Pharmacol. Ther. 63: 397-402.
10. Koster AS, Noordhoek J (1983) Glucuronidation in isolated perfused rat intestinal segments after mucosal and serosal administration of 1-naphthol. J Pharm Exp Ther 226: 533-538.
11. Libersa CC, Brique SA, Motte KB, Caron JF, Guedon-Moreau LM, Humbert L (2000) Dramatic inhibition of amiodarone metabolism induced by grapefruit juice. Br J Clin Pharmacol 49: 373-378.
12. Mohri K, Uesawa Y, Sagawa K (2000) Effects of long-term grapefruit juice ingestion on nifedipine pharmacokinetics: induction of rat hepatic P-450 by grapefruit juice. Drug Met Disp 28: 482-486.
13. Saitoh H, Aungst BJ (1995) Possible involvement of multiple P-glycoprotein-mediated Efflux systems in the transport of verapamil and other organic cations across rat intestine. Pharm Res 12: 1304-1310.
14. Schmiedlin-Ren P, Edwards DJ, Fitzsimmons ME, He K, Lown KS, Woster PM, Tahman A, Thummel KE, Fisher JM, Hollenberg PF, Watkins PB (1999) Mechanism of enhanced oral availability of CYP 3A substrates by grapefruit constituents: decreased enterocyte CYP 3A concentration and mechanism-based inactivation by furanocoumarins. Drug Met Disp 25: 1228-1234.
15. Schulte KL, Meyer-Sabellek WA, Haertenberger A, Thiede HM, Roecker L, Distler A, Gotzen R (1986) Antihypertensive and metabolic effects of diltiazem and nifedipine. Hypertension 8: 859-65.
16. Shimomura S, Wanwimolruk S, Chen JJ (2003) Drug interactions with grapefruit juice: an evidence-based overview. Pharmacy Times (https:// secure.pharmacytimes.com/lessons/200303-02.asp).
17. Sigusch H, Henschel L, Kraul H, Merkel U, Hoffmann A (1994) Lack of effect of grapefruit juice on diltiazem bioavailability in human subjects. Pharmazie 49: 675-679.
18. Soldner A, Christians U, Susanto M, Wacher VJ, Silverman JA, Benet LS (1999) Grapefruit juice activates P-glycoprotein-mediated drug transport. Pharm. Res 16: 478-485.
19. Tian R, Koyabu N, Takanaga H, Matsuo H, Ohtani H, Sawada Y (2002) Effects of grapefruit juice and orange juice on the intestinal efflux of P-glycoprotein substances. Pharm Res 19: 802-809.
20. Varma MVS, Panchangula R, Bansal T, Kaul CL (2005) Co-treatment with grapefruit juice inhibits while chronic administration activates intestinal P-glycoprotein-mediated drug efflux. Pharmazie 60: 922-927.
21. Yoshihara SI, Mizutare T, Makishima M, Suzuki N, Fujimoto N, Igarashi K, Ohta S (2004) Potent estrogenic metabolites of bisphenol A and bisphenol B formed by rat liver S9 fraction: their structures and estrogenic potency. Toxicol Sci 78: 50-59.